Here are five insights.
1. Recently, Stryker’s spine segment has seen a push in demand for target coil and 3-D printed interbody tritanium products.
2. Zacks estimates Stryker’s spine and neurotechnology revenues to be around $561 million in the first quarter of 2018, an 8.9 percent increase year-over-year.
3. Stryker’s last reported quarter put spine and neurotechnology sales at $586 million, up 10.3 percent year-over-year. The company attributed the jump to organic growth.
4. Revenues for the first quarter of 2018 are anticipated to hit $187 million within the spine segment, a 1.6 percent year-over-year increase.
5. Revenues for the first quarter of 2018 are projected to hi $373 million within the neurotechnology segment, representing a 12.7 percent year-over-year increase.
More articles on devices and implants:
NovoStitch Pro Meniscal Repair System receives FDA 510(k) clearance: 4 insights
Global spinal fusion devices market to grow at 4.6% CAGR through 2025: 4 observations
Dr. Richard Moore performs 1st surgery with Zimmer Biomet’s Persona Trabecular Metal Tibia: 5 notes
